Valuation check: AVGR's profit margin is -145.15%, below the Healthcare sector average of 13.76%.
Get informed when a big investor buys or sells
+ FollowAs of Sep 2024
Trailing 12 months ending Sep 2024
The latest profit margin for AVGR is -145.15% as of September 2024. That compares with -193.27% in the prior-year period — up 24.9% year over year. That is below the Healthcare sector average of 13.76%. Investors often review this figure alongside Avinger's historical trend and sector peers before judging valuation or financial health.
Over the past year, AVGR's profit margin moved from -193.27% to -145.15% — a 24.9% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Avinger's valuation or profitability profile.
Against Healthcare companies, AVGR currently prints -145.15% for profit margin, while the sector average sits near 13.76%. That is roughly 1154.9% below the sector mean. Large gaps often invite a closer look at Avinger's growth, margins, and balance sheet.
Profit Margin shows how effectively Avinger converts resources into returns. At -145.15%, AVGR may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -193.27% in the prior-year period — up 24.9% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting AVGR's profit margin (-145.15%), review year-over-year change from -193.27%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.